Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Caraco Pharmaceutical Laboratories Ltd

Caraco Pharmaceutical Laboratories Ltd (CPD) Stock Overview

Explore Caraco Pharmaceutical Laboratories Ltd’s financial performance, market position, analyst ratings, and future outlook.

CPD●AMEX
HealthcareMedical - Pharmaceuticals
$5.25
$0.00(0.00%)
U.S. Market opens in 11h 45m

Caraco Pharmaceutical Laboratories Ltd (CPD)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E RatioN/A
EPS (TTM)N/A
ROEN/A
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

CPD Stock Analysis & Investment Overview (AMEX)

Our AI-powered analysis of Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Caraco Pharmaceutical Laboratories Ltd's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of CPD on the AMEX shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the AMEX listing.

Key metrics behind Caraco Pharmaceutical Laboratories Ltd's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of CPD on the AMEX.

Price Performance (AMEX: CPD)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

NaN
NaN
1150 Elijah McCoy Drive, Detroit, NaN, 48202

Company Facts

IPO DateMar 1, 1994
CountryUS

Frequently Asked Questions